• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Pseudomonas Risks in Bronchiectasis Vary Sharply Across Patient Inflammatory Phenotypes

by
November 13, 2026
in Health
Reading Time: 3 mins read
0
Pseudomonas Risks in Bronchiectasis Vary Sharply Across Patient Inflammatory Phenotypes

Pseudomonas Risks in Bronchiectasis Vary Sharply Across Patient Inflammatory Phenotypes

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Chronic bacterial colonisation by Pseudomonas aeruginosa is linked to markedly different clinical outcomes depending on a patient’s underlying airway inflammatory phenotype, according to a retrospective cohort study of individuals with stable bronchiectasis. While overall analyses across the entire cohort did not reveal a statistically significant link between Pseudomonas aeruginosa colonisation and exacerbation rates, phenotype-stratified evaluations showed that the pathogen’s presence doubled the risk of general exacerbations in patients displaying a neutrophilic inflammatory profile and dramatically increased the likelihood of severe, hospital-requiring exacerbations among those with a mixed-granulocytic profile.

A central challenge in managing the disorder has been refining prognostic risk stratification, particularly because the clinical impact of chronic Pseudomonas aeruginosa colonisation has remained poorly understood across varying patient inflammation profiles. To explore whether the pathogen selectively drives distinct risks depending on inflammatory phenotypes, investigators analysed clinical records from 625 stable bronchiectasis patients evaluated at a single centre, aiming to identify vulnerable subgroups that may benefit from tailored management strategies.

Patients within the study cohort were categorised into four distinct inflammatory phenotypes based on routine peripheral blood cell counts. The investigators defined the subgroups using combined baseline blood eosinophil and neutrophil counts, applying cut-offs of 300 cells per microlitre for eosinophils and 4990 cells per microlitre for neutrophils. Through this classification system, 331 patients were identified as having a paucigranulocytic phenotype, 204 patients presented with a neutrophilic phenotype, 47 demonstrated an eosinophilic phenotype, and 43 individuals were classified as exhibiting a mixed-granulocytic phenotype.

Across the entire 625-patient cohort, chronic Pseudomonas aeruginosa colonisation was documented in 10.7 percent of participants, representing 67 individuals. However, the prevalence of colonisation varied widely among the inflammatory subsets, peaking at 20.9 percent within the mixed-granulocytic group, where 9 out of 43 patients harboured the pathogen. The study monitored acute exacerbations as primary endpoints, tracking both the time to a patient’s first exacerbation and the binary occurrence of flare-ups within one year, with hospital-requiring events evaluated as an indicator of severe disease.

When investigators evaluated the study population as an unstratified whole, Pseudomonas aeruginosa colonisation showed no statistically significant association with either overall exacerbation timing or subsequent hospitalisations. However, adjusting for clinical covariates within stratified models revealed pronounced phenotype-specific disparities. In patients with the neutrophilic phenotype, colonisation was associated with a significantly shortened time to first exacerbation, yielding an adjusted hazard ratio of 2.18, alongside an adjusted relative risk of 1.82 for experiencing an exacerbation within one year.

A contrasting pattern of risk emerged among individuals exhibiting the mixed-granulocytic phenotype. In this subgroup, Pseudomonas aeruginosa colonisation significantly shortened the time to first hospitalisation, producing an adjusted hazard ratio of 10.46, and substantially increased the risk of hospital-requiring exacerbations within a single year, with an adjusted relative risk of 5.33. Statistical interaction tests confirmed that the pathogen’s impact was non-uniform across inflammatory profiles, yielding adjusted interaction p-values of 0.030 for first exacerbation and 0.047 for first hospitalisation. Sensitivity analyses applying overlap weighting further corroborated these phenotype-specific risk profiles.

To investigate biological mechanisms underpinning these clinical differences, researchers performed exploratory immune profiling on bronchoalveolar lavage fluid collected from available patient subsets. This exploratory assessment identified elevated local concentrations of interleukin-2, interleukin-4, and CD8+CD28+ T cells in both neutrophilic and mixed-granulocytic phenotypes colonised by Pseudomonas aeruginosa. In addition, distinct cytokine patterns emerged between phenotypes: elevations of interleukin-12 and interferon-alpha were confined strictly to colonised neutrophilic patients, whereas elevated levels of CD4+CD29+ T cells were unique to the mixed-granulocytic group.

The study authors concluded that chronic Pseudomonas aeruginosa colonisation exhibits heterogeneous prognostic implications that depend heavily on patient inflammatory background. While neutrophilic patients face an elevated propensity toward overall exacerbations, mixed-granulocytic patients show acute vulnerability to severe flare-ups requiring hospital admission. These findings suggest that integrating peripheral inflammatory phenotypes into clinical evaluation may improve prognostic risk stratification and guide targeted pathogen management, although the researchers noted the single-centre retrospective design as a defining limitation of the study.

Subject of Research: Differential impact of Pseudomonas aeruginosa colonisation across bronchiectasis inflammatory phenotypes

Article Title: Refining prognostic risk stratification in bronchiectasis: the heterogeneous role of Pseudomonas aeruginosa by inflammatory phenotype

Article References: Wang, Y., Zhang, R., Liu, R., Ren, J., Ben, S., Wu, J., Tang, R., Gao, J., Shao, P., Liao, R., Zhang, M., & Ding, F. (2026). Refining prognostic risk stratification in bronchiectasis: the heterogeneous role of Pseudomonas aeruginosa by inflammatory phenotype. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-026-04970-0

Image Credits: AI Generated

DOI: 10.1186/s12890-026-04970-0

Keywords: bronchiectasis, Pseudomonas aeruginosa, bacterial colonisation, inflammatory phenotypes, neutrophilic inflammation, mixed-granulocytic phenotype, paucigranulocytic phenotype, eosinophilic phenotype, pulmonary exacerbations, hospitalisation risk, bronchoalveolar lavage fluid, airway inflammation, retrospective cohort study, risk stratification, immune profiling, cytokines, respiratory medicine

News Source: Ophelia Keating. (November 13, 2026). Pseudomonas Risks in Bronchiectasis Vary Sharply Across Patient Inflammatory Phenotypes. Scienmag.

Tags: airway inflammationbacterial colonisationbronchiectasisbronchoalveolar lavage fluidcytokineseosinophilic phenotypehospitalisation riskimmune profilinginflammatory phenotypesmixed-granulocytic phenotypeneutrophilic inflammationpaucigranulocytic phenotypePseudomonas aeruginosapulmonary exacerbationsrespiratory medicineretrospective cohort studyrisk stratification
Share12Tweet7Share2ShareShareShare1

Related Posts

Home EEG Study Shows Gaboxadol Modulates Brain Oscillations in Fragile X Syndrome

Home EEG Study Shows Gaboxadol Modulates Brain Oscillations in Fragile X Syndrome

November 19, 2026
Incidental Abdominal Splenosis Resembling Metastatic Cancer Found During Elective Hernia Repair

Incidental Abdominal Splenosis Resembling Metastatic Cancer Found During Elective Hernia Repair

November 19, 2026

Single-Camera Video Predicts Knee Contact Forces but Lacks Clinical Accuracy

November 19, 2026

Rural South Africans Face Systemic Barriers in Managing Chronic Non-Communicable Diseases

November 19, 2026

POPULAR NEWS

  • Somatic Symptom Burden in Oral Health Clinic Patients Shifted Modestly Across Pandemic

    Somatic Symptom Burden in Oral Health Clinic Patients Shifted Modestly Across Pandemic

    29 shares
    Share 12 Tweet 7
  • Multicenter ICU Study Identifies Nurse Knowledge Gaps in Pneumonia Prevention

    29 shares
    Share 12 Tweet 7
  • Study Finds One-Third of Ethiopian Neuropsychiatric Patients Exhibit Harmful Alcohol Use

    29 shares
    Share 12 Tweet 7
  • Low-Dose Epidural Analgesia Modestly Lengthens Labor Stages in Low-Risk Women

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Home EEG Study Shows Gaboxadol Modulates Brain Oscillations in Fragile X Syndrome

Incidental Abdominal Splenosis Resembling Metastatic Cancer Found During Elective Hernia Repair

Review Identifies Molecular Networks Driving Colitis-Associated Colorectal Cancer and Emerging Therapies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.